119 related articles for article (PubMed ID: 4076327)
21. Effective control of moderate-dose cisplatin-induced emesis by a short-course regimen including metoclopramide, chlorpromazine and hydrocortisone: results of a randomized trial with metoclopramide alone.
Pollera CF; Calabresi F
Oncology; 1989; 46(4):238-44. PubMed ID: 2740067
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesis.
Pollera CF; Conti EM; De Nigris A; Calabresi F
Oncology; 1987; 44(2):73-7. PubMed ID: 3554084
[TBL] [Abstract][Full Text] [Related]
23. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine].
Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905
[TBL] [Abstract][Full Text] [Related]
24. Progress in the control of acute and delayed emesis induced by cisplatin.
Gandara DR
Eur J Cancer; 1991; 27 Suppl 1():S9-11; discussion S22. PubMed ID: 1831633
[TBL] [Abstract][Full Text] [Related]
25. [Antiemetic combination of metoclopramide and methylprednisolone for cisplatin-induced vomiting].
Saito H; Amano H; Yasuda Y; Tsunekawa H; Fujimoto K; Yoshii S; Shimokata K
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1980-2. PubMed ID: 4051514
[TBL] [Abstract][Full Text] [Related]
26. Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis.
Saller R; Hellenbrecht D; Briemann L; Hellstern A; Hess H; Mitrou P; Hodgson M; Achtert G; Brockmann P; Hausleiter HJ
Clin Pharmacol Ther; 1985 Jan; 37(1):43-7. PubMed ID: 4038385
[TBL] [Abstract][Full Text] [Related]
27. [Antiemetic efficacy of high-dose metoclopramide, diphenhydramine, methylprednisolone and diazepam on chemotherapy-induced emesis in gynecological malignancy].
Hayashi Y; Iwasaka T; Hachisuga T; Fukuda K; Tanaka T; Matsuo N; Sugimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):875-9. PubMed ID: 3418195
[TBL] [Abstract][Full Text] [Related]
28. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
[TBL] [Abstract][Full Text] [Related]
29. Optimizing metoclopramide control of cisplatin-induced emesis.
Meyer BR; Lewin M; Drayer DE; Pasmantier M; Lonski L; Reidenberg MM
Ann Intern Med; 1984 Mar; 100(3):393-5. PubMed ID: 6538075
[TBL] [Abstract][Full Text] [Related]
30. Antiemetic combination for cisplatin-induced emesis. Results from a controlled study.
Martín Jiménez M; Diaz-Rubio E
Bull Cancer; 1986; 73(3):294-8. PubMed ID: 3756365
[TBL] [Abstract][Full Text] [Related]
31. Anthropometric and pharmacotherapeutic variables on acute emesis induced by cisplatin-containing chemotherapy.
Catalán Arlandis JL; Jiménez Torres NV
Ann Pharmacother; 2000 May; 34(5):573-9. PubMed ID: 10852082
[TBL] [Abstract][Full Text] [Related]
32. [Recent improvements in antiemetic therapy].
Roila F; Palladino MA; Ciccarese G; Basurto C
Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
[TBL] [Abstract][Full Text] [Related]
33. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
[TBL] [Abstract][Full Text] [Related]
34. Antiemetic efficacy of moderately high-dose metoclopramide in patients receiving varying doses of cisplatin. Controlled comparison with a combination of methylprednisolone and metoclopramide.
Ell C; König HJ; Brockmann P; Domschke S; Domschke W
Oncology; 1985; 42(6):354-7. PubMed ID: 4069550
[TBL] [Abstract][Full Text] [Related]
35. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
[TBL] [Abstract][Full Text] [Related]
36. [Recent advances in the management of chemotherapy-induced emesis].
Murakami M; Ota K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):401-11. PubMed ID: 3006594
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.
Saller R; Hellenbrecht D
Cancer Treat Rep; 1985 Nov; 69(11):1301-3. PubMed ID: 3912040
[TBL] [Abstract][Full Text] [Related]
38. Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
Gordon CJ; Pazdur R; Ziccarelli A; Cummings G; Al-Sarraf M
Cancer; 1989 Feb; 63(3):578-82. PubMed ID: 2912533
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
[TBL] [Abstract][Full Text] [Related]
40. Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis.
Roila F; Basurto C; Bracarda S; Sassi M; Lupattelli M; Picciafuoco M; Boschetti E; Tonato M; Del Favero A
Eur J Cancer; 1991; 27(2):119-21. PubMed ID: 1827271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
